LPC18:0 Secreted by Exogenous Neural Stem Cells Potentiates Neurogenesis and Functional Recovery via GPR55-Mediated Signalling in Spinal Cord Injury

Abstract

Spinal cord injury (SCI) is a devastating condition with limited therapeutic options. Although neural stem cell (NSC) transplantation shows regenerative potential, its efficacy is constrained by the hostile post-injury microenvironment. Here, we employed untargeted metabolomics to investigate metabolic reprogramming induced by NSC-loaded multichannel collagen scaffolds in a rat SCI model. NSC transplantation significantly enhanced functional recovery and structural remodelling, concomitant with elevated neurogenesis and attenuated gliosis. Metabolomic profiling identified lysophosphatidylcholine 18:0 (LPC18:0) as a key NSC-derived metabolite. Mechanistically, LPC18:0 promoted the differentiation of endogenous NSCs into neurons via the GPR55/AKT/GSK3β signalling axis, as validated by receptor-specific inhibition. In vivo administration of LPC18:0 improved motor function, axonal regeneration and recruitment of immature neurons. These findings reveal a novel metabolic mechanism underlying NSC-based therapy, positioning LPC18:0/GPR55/AKT/GSK3β signalling as a therapeutic target for SCI recovery.

References

[1] GBD Spinal Cord Injuries Collaborators, “Global, Regional, and National Burden of Spinal Cord Injury, 1990-2019: A Systematic Analysis for the Global Burden of Disease Study 2019,” Lancet Neurology 22, no. 11 (2023): 1026–1047, https://doi.org/10.1016/S1474-4422(23)00287-9.

[2] D. J. Hellenbrand, C. M. Quinn, Z. J. Piper, C. N. Morehouse, J. A. Fixel, and A. S. Hanna, “Inflammation After Spinal Cord Injury: A Review of the Critical Timeline of Signaling Cues and Cellular Infiltration,” Journal of Neuroinflammation 18, no. 1 (2021): 284, https://doi.org/10.1186/s12974-021-02337-2.

[3] C. S. Sousa, A. Monteiro, A. J. Salgado, and N. A. Silva, “Combinatorial Therapies for Spinal Cord Injury Repair,” Neural Regeneration Research 20, no. 5 (2025): 1293–1308, https://doi.org/10.4103/NRR.NRR-D-24-00061.

[4] B. Mili and O. P. Choudhary, “Advancements and Mechanisms of Stem Cell-Based Therapies for Spinal Cord Injury in Animals,” International Journal of Surgery 110, no. 10 (2024): 6182–6197, https://doi.org/10.1097/JS9.0000000000001074.

[5] C. S. Ahuja, A. Mothe, M. Khazaei, et al., “The Leading Edge: Emerging Neuroprotective and Neuroregenerative Cell-Based Therapies for Spinal Cord Injury,” Stem Cells Translational Medicine 9, no. 12 (2020): 1509–1530, https://doi.org/10.1002/sctm.19-0135.

[6] P. Assinck, G. J. Duncan, B. J. Hilton, J. R. Plemel, and W. Tetzlaff, “Cell Transplantation Therapy for Spinal Cord Injury,” Nature Neuroscience 20, no. 5 (2017): 637–647, https://doi.org/10.1038/nn.4541.

[7] S. M. Hosseini, B. Borys, and S. Karimi-Abdolrezaee, “Neural Stem Cell Therapies for Spinal Cord Injury Repair: An Update on Recent Preclinical and Clinical Advances,” Brain 147, no. 3 (2024): 766–793, https://doi.org/10.1093/brain/awad392.

[8] S. Nishimura, A. Yasuda, H. Iwai, et al., “Time-Dependent Changes in the Microenvironment of Injured Spinal Cord Affects the Therapeutic Potential of Neural Stem Cell Transplantation for Spinal Cord Injury,” Molecular Brain 6 (2013): 3, https://doi.org/10.1186/1756-6606-6-3.

[9] S. M. Hosseini, A. Alizadeh, N. Shahsavani, J. Chopek, J. E. Ahlfors, and S. Karimi-Abdolrezaee, “Suppressing CSPG/LAR/PTPsigma Axis Facilitates Neuronal Replacement and Synaptogenesis by Human Neural Precursor Grafts and Improves Recovery After Spinal Cord Injury,” Journal of Neuroscience 42, no. 15 (2022): 3096–3121, https://doi.org/10.1523/JNEUROSCI.2177-21.2022.

[10] M. Khazaei, C. S. Ahuja, H. Nakashima, et al., “GDNF Rescues the Fate of Neural Progenitor Grafts by Attenuating Notch Signals in the Injured Spinal Cord in Rodents,” Science Translational Medicine 12, no. 525 (2020): eaau3538, https://doi.org/10.1126/scitranslmed.aau3538.

[11] M. Bonora, C. Giorgi, and P. Pinton, “Molecular Mechanisms and Consequences of Mitochondrial Permeability Transition,” Nature Reviews. Molecular Cell Biology 23, no. 4 (2022): 266–285, https://doi.org/10.1038/s41580-021-00433-y.

[12] J. Chen, J. Chen, C. Yu, et al., “Metabolic Reprogramming: A New Option for the Treatment of Spinal Cord Injury,” Neural Regeneration Research 20, no. 4 (2025): 1042–1057, https://doi.org/10.4103/NRR.NRR-D-23-01604.

[13] X. Chen, C. Chen, J. Hao, et al., “AKR1B1 Upregulation Contributes to Neuroinflammation and Astrocytes Proliferation by Regulating the Energy Metabolism in Rat Spinal Cord Injury,” Neurochemical Research 43, no. 8 (2018): 1491–1499, https://doi.org/10.1007/s11064-018-2570-3.

[14] T. Zrzavy, C. Schwaiger, I. Wimmer, et al., “Acute and Non-Resolving Inflammation Associate With Oxidative Injury After Human Spinal Cord Injury,” Brain 144, no. 1 (2021): 144–161, https://doi.org/10.1093/brain/awaa360.

[15] E. A. Bykowski, J. N. Petersson, S. Dukelow, et al., “Identification of Serum Metabolites as Prognostic Biomarkers Following Spinal Cord Injury: A Pilot Study,” Metabolites 13, no. 5 (2023): 605, https://doi.org/10.3390/metabo13050605.

[16] R. Zhou, J. Chen, Y. Tang, et al., “Multi-Omics Uncovers Immune-Modulatory Molecules in Plasma Contributing to Resistance Exercise-Ameliorated Locomotor Disability After Incomplete Spinal Cord Injury,” Genome Medicine 17, no. 1 (2025): 10, https://doi.org/10.1186/s13073-025-01434-8.

[17] R. Tzekov, C. Dawson, M. Orlando, et al., “Sub-Chronic Neuropathological and Biochemical Changes in Mouse Visual System After Repetitive Mild Traumatic Brain Injury,” PLoS One 11, no. 4 (2016): e0153608, https://doi.org/10.1371/journal.pone.0153608.

[18] J. Nagai and H. Ueda, “Pre-Emptive Morphine Treatment Abolishes Nerve Injury-Induced Lysophospholipid Synthesis in Mass Spectrometrical Analysis,” Journal of Neurochemistry 118, no. 2 (2011): 256–265, https://doi.org/10.1111/j.1471-4159.2011.07297.x.

[19] M. Hanada, Y. Sugiura, R. Shinjo, et al., “Spatiotemporal Alteration of Phospholipids and Prostaglandins in a Rat Model of Spinal Cord Injury,” Analytical and Bioanalytical Chemistry 403, no. 7 (2012): 1873–1884, https://doi.org/10.1007/s00216-012-5900-3.

[20] J. N. Kang, Z. F. Sun, X. Y. Li, et al., “Alterations in Gut Microbiota Are Related to Metabolite Profiles in Spinal Cord Injury,” Neural Regeneration Research 18, no. 5 (2023): 1076–1083, https://doi.org/10.4103/1673-5374.355769.

[21] S. Qiu, Y. Cai, H. Yao, et al., “Small Molecule Metabolites: Discovery of Biomarkers and Therapeutic Targets,” Signal Transduction and Targeted Therapy 8, no. 1 (2023): 132, https://doi.org/10.1038/s41392-023-01399-3.

[22] H. Quan, Y. H. Hur, C. Xin, et al., “Stearoyl Lysophosphatidylcholine Enhances the Phagocytic Ability of Macrophages Through the AMP-Activated Protein Kinase/p38 Mitogen Activated Protein Kinase Pathway,” International Immunopharmacology 39 (2016): 328–334, https://doi.org/10.1016/j.intimp.2016.07.014.

[23] S. Liu, Y. Y. Xie, L. D. Wang, et al., “A Multi-Channel Collagen Scaffold Loaded With Neural Stem Cells for the Repair of Spinal Cord Injury,” Neural Regeneration Research 16, no. 11 (2021): 2284–2292, https://doi.org/10.4103/1673-5374.310698.

[24] M. Ma, D. M. Basso, P. Walters, B. T. Stokes, and L. B. Jakeman, “Behavioral and Histological Outcomes Following Graded Spinal Cord Contusion Injury in the C57Bl/6 Mouse,” Experimental Neurology 169, no. 2 (2001): 239–254, https://doi.org/10.1006/exnr.2001.7679.

[25] L. W. Sumner, A. Amberg, D. Barrett, et al., “Proposed Minimum Reporting Standards for Chemical Analysis Chemical Analysis Working Group (CAWG) Metabolomics Standards Initiative (MSI),” Metabolomics 3, no. 3 (2007): 211–221, https://doi.org/10.1007/s11306-007-0082-2.

[26] R. Lee, I. S. Kim, N. Han, S. Yun, K. I. Park, and K. H. Yoo, “Real-Time Discrimination Between Proliferation and Neuronal and Astroglial Differentiation of Human Neural Stem Cells,” Scientific Reports 4 (2014): 6319, https://doi.org/10.1038/srep06319.

[27] S. Zhang, M. Wu, C. Peng, G. Zhao, and R. Gu, “GFAP Expression in Injured Astrocytes in Rats,” Experimental and Therapeutic Medicine 14, no. 3 (2017): 1905–1908, https://doi.org/10.3892/etm.2017.4760.

[28] L. Gaetani, K. Blennow, P. Calabresi, M. Di Filippo, L. Parnetti, and H. Zetterberg, “Neurofilament Light Chain as a Biomarker in Neurological Disorders,” Journal of Neurology, Neurosurgery, and Psychiatry 90, no. 8 (2019): 870–881, https://doi.org/10.1136/jnnp-2018-320106.

[29] R. X. Liu, J. Ma, B. Wang, T. Tian, N. Guo, and S. J. Liu, “No DCX-Positive Neurogenesis in the Cerebral Cortex of the Adult Primate,” Neural Regeneration Research 15, no. 7 (2020): 1290–1299, https://doi.org/10.4103/1673-5374.272610.

[30] Q. Qin, B. Wang, J. Wang, et al., “A Comprehensive Strategy for Studying Protein-Metabolite Interactions by Metabolomics and Native Mass Spectrometry,” Talanta 194 (2019): 63–72, https://doi.org/10.1016/j.talanta.2018.10.010.

[31] A. Drzazga, A. Sowinska, A. Krzeminska, P. Rytczak, M. Koziolkiewicz, and E. Gendaszewska-Darmach, “Lysophosphatidylcholine Elicits Intracellular Calcium Signaling in a GPR55-Dependent Manner,” Biochemical and Biophysical Research Communications 489, no. 2 (2017): 242–247, https://doi.org/10.1016/j.bbrc.2017.05.145.

[32] J. Ren, L. Yu, J. Lin, et al., “Elevated 18:1 Lysophosphatidylcholine Contributes to Neuropathic Pain in Peripheral Nerve Injury,” Regional Anesthesia and Pain Medicine (2025), https://doi.org/10.1136/rapm-2024-106195.

[33] J. D. Hill, V. Zuluaga-Ramirez, S. Gajghate, et al., “Activation of GPR55 Induces Neuroprotection of Hippocampal Neurogenesis and Immune Responses of Neural Stem Cells Following Chronic, Systemic Inflammation,” Brain, Behavior, and Immunity 76 (2019): 165–181, https://doi.org/10.1016/j.bbi.2018.11.017.

[34] C. Li, Y. Luo, and S. Li, “The Roles of Neural Stem Cells in Myelin Regeneration and Repair Therapy After Spinal Cord Injury,” Stem Cell Research & Therapy 15, no. 1 (2024): 204, https://doi.org/10.1186/s13287-024-03825-x.

[35] L. Wertheim, R. Edri, Y. Goldshmit, et al., “Regenerating the Injured Spinal Cord at the Chronic Phase by Engineered iPSCs-Derived 3D Neuronal Networks,” Advanced Science 9, no. 11 (2022): e2105694, https://doi.org/10.1002/advs.202105694.

[36] S. Yao, M. Pang, Y. Wang, et al., “Mesenchymal Stem Cell Attenuates Spinal Cord Injury by Inhibiting Mitochondrial Quality Control-Associated Neuronal Ferroptosis,” Redox Biology 67 (2023): 102871, https://doi.org/10.1016/j.redox.2023.102871.

[37] B. J. Cummings, N. Uchida, S. J. Tamaki, et al., “Human Neural Stem Cells Differentiate and Promote Locomotor Recovery in Spinal Cord-Injured Mice,” Proceedings of the National Academy of Sciences of the United States of America 102, no. 39 (2005): 14069–14074, https://doi.org/10.1073/pnas.0507063102.

[38] J. Yan, L. Xu, A. M. Welsh, et al., “Extensive Neuronal Differentiation of Human Neural Stem Cell Grafts in Adult Rat Spinal Cord,” PLoS Medicine 4, no. 2 (2007): e39, https://doi.org/10.1371/journal.pmed.0040039.

[39] S. Karimi-Abdolrezaee, E. Eftekharpour, J. Wang, C. M. Morshead, and M. G. Fehlings, “Delayed Transplantation of Adult Neural Precursor Cells Promotes Remyelination and Functional Neurological Recovery After Spinal Cord Injury,” Journal of Neuroscience 26, no. 13 (2006): 3377–3389, https://doi.org/10.1523/JNEUROSCI.4184-05.2006.

[40] L. Cao, Z. Shangguan, Y. Zhang, et al., “Vegfr3 Activation of Pkd2l1(+) CSF-cNs Triggers the Neural Stem Cell Response in Spinal Cord Injury,” Cellular Signalling 130 (2025): 111675, https://doi.org/10.1016/j.cellsig.2025.111675.

[41] S. Liu, C. Fan, Y. Xie, L. Wang, Y. Cui, and B. Wang, “Collagen Scaffold Loaded Allogeneic Neural Stem Cells Promoted Locomotion Recovery of Spinal Cord Injury Mainly Through Secreting Neurotrophic Factors,” Materials and Design 219 (2022): 110804.

[42] K. Hwang, K. Jung, I. S. Kim, et al., “Glial Cell Line-Derived Neurotrophic Factor-Overexpressing Human Neural Stem/Progenitor Cells Enhance Therapeutic Efficiency in Rat With Traumatic Spinal Cord Injury,” Experimental Neurobiology 28, no. 6 (2019): 679–696, https://doi.org/10.5607/en.2019.28.6.679.

[43] J. Zhang, J. Shang, H. Ding, et al., “Nicotinamide Riboside Promotes the Proliferation of Endogenous Neural Stem Cells to Repair Spinal Cord Injury,” Stem Cell Reviews and Reports 20, no. 7 (2024): 1854–1868, https://doi.org/10.1007/s12015-024-10747-x.

[44] R. Peng, L. Zhang, Y. Xie, S. Guo, X. Cao, and M. Yang, “Spatial Multi-Omics Analysis of the Microenvironment in Traumatic Spinal Cord Injury: A Narrative Review,” Frontiers in Immunology 15 (2024): 1432841, https://doi.org/10.3389/fimmu.2024.1432841.

[45] S. Dolci, L. Mannino, E. Bottani, et al., “Therapeutic Induction of Energy Metabolism Reduces Neural Tissue Damage and Increases Microglia Activation in Severe Spinal Cord Injury,” Pharmacological Research 178 (2022): 106149, https://doi.org/10.1016/j.phrs.2022.106149.

[46] P. Cheng, K. Chen, W. Yu, et al., “Protein Phosphatase 2A (PP2A) Activation Promotes Axonal Growth and Recovery in the CNS,” Journal of the Neurological Sciences 359, no. 1–2 (2015): 48–56, https://doi.org/10.1016/j.jns.2015.10.025.

[47] M. Stenudd, H. Sabelstrom, and J. Frisen, “Role of Endogenous Neural Stem Cells in Spinal Cord Injury and Repair,” JAMA Neurology 72, no. 2 (2015): 235–237, https://doi.org/10.1001/jamaneurol.2014.2927.

[48] N. K. Liu and X. M. Xu, “Phospholipase A2 and Its Molecular Mechanism After Spinal Cord Injury,” Molecular Neurobiology 41, no. 2–3 (2010): 197–205, https://doi.org/10.1007/s12035-010-8101-0.

[49] T. Karaki, H. Haniu, Y. Matsuda, and T. Tsukahara, “Lysophospholipids-Potent Candidates for Brain Food, Protects Neuronal Cells Against Alpha-Synuclein Aggregation,” Biomedicine & Pharmacotherapy 156 (2022): 113891, https://doi.org/10.1016/j.biopha.2022.113891.

[50] Wuhanqimuge, A. Itakura, Y. Matsuki, M. Tanaka, and M. Arioka, “Lysophosphatidylcholine Enhances NGF-Induced MAPK and Akt Signals Through the Extracellular Domain of TrkA in PC12 Cells,” FEBS Open Bio 3 (2013): 243–251, https://doi.org/10.1016/j.fob.2013.05.003.

[51] A. Negm, K. Stobbe, S. Ben Fradj, et al., “Acid-Sensing Ion Channel 3 Mediates Pain Hypersensitivity Associated With High-Fat Diet Consumption in Mice,” Pain 165, no. 2 (2024): 470–486, https://doi.org/10.1097/j.pain.0000000000003030.

[52] H. Sabelstrom, M. Stenudd, P. Reu, et al., “Resident Neural Stem Cells Restrict Tissue Damage and Neuronal Loss After Spinal Cord Injury in Mice,” Science 342, no. 6158 (2013): 637–640, https://doi.org/10.1126/science.1242576.

[53] C. Wang, T. Xu, B. B. Lachance, et al., “Critical Roles of Sphingosine Kinase 1 in the Regulation of Neuroinflammation and Neuronal Injury After Spinal Cord Injury,” Journal of Neuroinflammation 18, no. 1 (2021): 50, https://doi.org/10.1186/s12974-021-02092-4.

[54] Y. Ikeno, N. Konno, S. H. Cheon, et al., “Secretory Phospholipases A2 Induce Neurite Outgrowth in PC12 Cells Through Lysophosphatidylcholine Generation and Activation of G2A Receptor,” Journal of Biological Chemistry 280, no. 30 (2005): 28044–28052, https://doi.org/10.1074/jbc.M503343200.

[55] J. D. Hill, V. Zuluaga-Ramirez, S. Gajghate, M. Winfield, and Y. Persidsky, “Activation of GPR55 Increases Neural Stem Cell Proliferation and Promotes Early Adult Hippocampal Neurogenesis,” British Journal of Pharmacology 175, no. 16 (2018): 3407–3421, https://doi.org/10.1111/bph.14387.

[56] J. E. Lauckner, J. B. Jensen, H. Y. Chen, H. C. Lu, B. Hille, and K. Mackie, “GPR55 Is a Cannabinoid Receptor That Increases Intracellular Calcium and Inhibits M Current,” Proceedings of the National Academy of Sciences of the United States of America 105, no. 7 (2008): 2699–2704, https://doi.org/10.1073/pnas.0711278105.

[57] C. M. Chern, Y. H. Wang, K. T. Liou, Y. C. Hou, C. C. Chen, and Y. C. Shen, “2-Methoxystypandrone Ameliorates Brain Function Through Preserving BBB Integrity and Promoting Neurogenesis in Mice With Acute Ischemic Stroke,” Biochemical Pharmacology 87, no. 3 (2014): 502–514, https://doi.org/10.1016/j.bcp.2013.11.018.

[58] S. Zhang, D. W. Kong, G. D. Ma, et al., “Long-Term Administration of Salvianolic Acid A Promotes Endogenous Neurogenesis in Ischemic Stroke Rats Through Activating Wnt3a/GSK3beta/Beta-Catenin Signaling Pathway,” Acta Pharmacologica Sinica 43, no. 9 (2022): 2212–2225, https://doi.org/10.1038/s41401-021-00844-9.

RIGHTS & PERMISSIONS

2025 The Author(s). Cell Proliferation published by Beijing Institute for Stem Cell and Regenerative Medicine and John Wiley & Sons Ltd.